Acacia Research Corp Files 8-K Amendment

TL;DR

ACACIA RESEARCH CORP filed an 8-K amendment on Jan 2, 2025, updating its Oct 18, 2024 report with financial statements/exhibits.

AI Summary

Acacia Research Corporation filed an amendment (8-K/A) on January 2, 2025, to its report originally dated October 18, 2024. The amendment pertains to financial statements and exhibits, with no specific financial figures or new material events detailed in the provided text.

Why It Matters

This filing is an amendment to a previous report, indicating a correction or addition to previously disclosed information, which could be important for understanding the company's latest disclosures.

Risk Assessment

Risk Level: low — The filing is an amendment to a previous report and does not introduce new material financial events or risks.

Key Players & Entities

• ACACIA RESEARCH CORPORATION (company) — Registrant
• October 18, 2024 (date) — Date of earliest event reported
• January 2, 2025 (date) — Filing date of the amendment
• Delaware (jurisdiction) — State of incorporation
• 767 Third Avenue, 6th Floor, New York, NY 10017 (address) — Principal executive offices and mail address

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share ACTG The Nasdaq Stock Marke

Filing Documents

• tm2432316d1_8ka.htm (8-K/A) — 34KB
• tm2432316d1_ex23-1.htm (EX-23.1) — 2KB
• tm2432316d1_ex99-1.htm (EX-99.1) — 306KB
• tm2432316d1_ex99-2.htm (EX-99.2) — 236KB
• tm2432316d1_ex99-3.htm (EX-99.3) — 494KB
• tm2432316d1_ex99-1img003.jpg (GRAPHIC) — 9KB
• tm2432316d1_ex99-1img004.jpg (GRAPHIC) — 4KB
• tm2432316d1_ex99-1img005.jpg (GRAPHIC) — 5KB
• 0001104659-25-000341.txt ( ) — 1359KB
• actg-20241018.xsd (EX-101.SCH) — 3KB
• actg-20241018_lab.xml (EX-101.LAB) — 33KB
• actg-20241018_pre.xml (EX-101.PRE) — 22KB
• tm2432316d1_8ka_htm.xml (XML) — 4KB

Financial Statements and Exhibits

Financial Statements and Exhibits. (a)

Financial statements of businesses acquired

Financial statements of businesses acquired . The Audited Consolidated Financial Statements of Deflecto Acquisition, Inc. and Subsidiaries as of and for the year ended December 31, 2023, and the notes related thereto, are filed as Exhibit 99.1 and incorporated herein by reference. The Unaudited Consolidated Financial Statements of Deflecto Acquisition, Inc. and Subsidiaries as of and for the six months ended June 30, 2024, and the notes related thereto, are filed as Exhibit 99.2 and incorporated herein by reference. (b) Pro forma financial information . The Unaudited Pro Forma Condensed Combined Financial Statements of the Company as of and for the six months ended June 30, 2024 and the year ended December 31, 2023, and the notes related thereto, are filed as Exhibit 99.3 and incorporated herein by reference. The Unaudited Pro Forma Condensed Combined Financial Statements give effect to the Transaction on the basis, and subject to the assumptions, set forth in accordance with Article 11 of Regulation S-X. (d) Exhibits Exhibit No. Description of Exhibit 23.1 Consent of Baker Tilly US LLP. 99.1 Audited Consolidated Financial Statements of Deflecto Acquisition, Inc. and Subsidiaries as of and for the year ended December 31, 2023. 99.2 Unaudited Consolidated Financial Statements of Deflecto Acquisition, Inc. and Subsidiaries as of and for the six months ended June 30, 2024. 99.3 Unaudited Pro Forma Condensed Combined Financial Statements of Acacia Research Corporation as of and for the six months ended June 30, 2024 and the year ended December 31, 2023. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 2, 2025 ACACIA RESEARCH CORPORATION By: /s/ Jason Soncini Name: Jason Soncini Title: General Counsel

View Full Filing

View this 8-K/A filing on SEC EDGAR